Navigation Links
Scientific Luminaries to Keynote at 3rd Annual PODD
Date:6/12/2013

New York, New York (PRWEB) June 12, 2013

The Conference Forum is pleased to announce the keynotes for the 3rd annual PODD: Partnership Opportunities in Drug Delivery event, which takes place on October 10-11 in Boston. PODD is strategic level networking event designed to bring drug delivery innovators together with key decision makers at pharmaceutical, biotechnology and medical device companies. This event provides the opportunity to learn about cutting-edge delivery technologies and meet with senior level executives and scientists.

To kick-off the PODD event, Robert Langer, PhD, David H. Koch Institute Professor at MIT will engage in a fireside style chat to discuss the difference between success and failure of drug delivery technologies.

On the second day of the conference George M. Whitesides, PhD, Woodford L. and Ann A. Flowers University Professor, Harvard University and Founding Core Faculty Member, Wyss Institute will address how drug delivery will disrupt the future of healthcare.

PODD is chaired by Barbara Lueckel, PhD, Global Business Development Director, Roche and features a wide range of drug delivery technologies, pharmaceutical and biotech business development panels, together with new discussions related to delivering biologics, role of drug delivery in the R&D pipeline, nanomedicine, and funding in the drug delivery sector.

We are excited to bring all the major components together that advance drug delivery partnerships," Valerie Bowling, Executive Director of the Conference Forum.

Other conference highlights include:
    ?    How drug delivery is disrupting the diagnostics industry
    ?    Who is funding drug delivery
    ?    The next paradigm on how biologics will be delivered
    ?    New deal structures and models
    ?    POV from heads of R&D on the role of drug delivery
    ?    Partnering and networking tools and facilities

To learn more about the PODD conference, visit http://www.theconferenceforum.org.

About the Conference Forum

The Conference Forum has a very specific focus – developing specialized events both public and private as well as research groups and advisory boards for professionals in the life science industry. We currently offer conferences for R&D leaders, Clinical Development professionals, young and established Biotech executives, and Drug Delivery specialists. Our mission is to create the best content in an ideal forum for the exchange of ideas among peers and networking for Pharmaceutical and Biotech professionals.

Related Links:
Dr Robert S. Langer, PhD, Biography
Dr George Whitesides, PhD, Biography
Barbara Lueckel, PhD, Biography

Read the full story at http://www.prweb.com/releases/2013/6/prweb10813366.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Steep Hill Laboratories and Halent Scientific Proudly Announce Historic Merger
2. Used Scientific Equipment Supplier, BMI Surplus, Partners with Universities During Sequester
3. Hemostemix Announces Formation of Scientific Advisory Board
4. DuPont Celebrates Scientific Innovation by Recognizing Young Professors
5. Pioneering Researchers Recognized for Scientific Achievements in Gene and Cell Therapy
6. Trigemina Presents at American Pain Society 32nd Annual Scientific Meeting
7. Emory Cardiologists Arshed Quyyumi And Javed Butler Join Stemedica Cardiology Division Scientific Advisory Board
8. Amarin, Pharmacyclics, Anthera Pharma, Star Scientific, and Impax Laboratories Under StockCalls Microscope
9. Heptares to Present at Upcoming Scientific and Biotech Industry Conferences
10. “Scientific And Medical Research On The Successful Treatment Of Type 1 + 2 Diabetes With Alkaline Reduced Water” is Reviewed in Today’s Bawell Water Ionizer Health Report
11. BioRestorative Therapies Announces Chairman of Its Scientific Advisory Board to Speak at Vatican
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... VANCOUVER, British Columbia and MENLO PARK, ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies, today announced that it will present at the ... on Monday, February 8, 2016 at 10:00 a.m. EST in ... Jeffrey Bacha , DelMar,s president and CEO, will provide an ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech Ltd. ... leading provider of biopharmaceutical products in China ... its board of directors received on February 4, 2016 ... from a consortium comprised of PKU V-Ming ( ... Co., Ltd., CICC Qianhai Development ( Shenzhen ...
(Date:2/3/2016)... , Feb. 3, 2016   ViaCyte, Inc ... the first pluripotent stem cell-derived islet replacement therapy ... clinical-stage development, today announced that ViaCyte and Janssen ... of Johnson & Johnson, have agreed to consolidate ... ViaCyte.  The agreement provides ViaCyte with an exclusive ...
(Date:2/3/2016)... NEW YORK and HOLLISTON, Mass., Feb. 3, ... (Nasdaq: HART ), a biotechnology company developing ... esophagus, trachea and bronchus, today announced that CEO ... BIO CEO & Investor Conference on ... in New York City . ...
Breaking Biology Technology:
(Date:1/27/2016)... 2016  Rite Track, Inc. a leading semiconductor equipment ... Chester, Ohio announced today the acquisition of PLUS ... in Austin, Texas , will significantly ... modifications, installations and technical support offerings for TEL Track ... commented, "PLUS has provided world class service including refurbishment, ...
(Date:1/22/2016)... DUBLIN , Jan. 22, 2016 /PRNewswire/ ... announced the addition of the "Global ... report to their offering. --> ... of the "Global Biometrics Market in ... offering. --> Research and ...
(Date:1/20/2016)... , Jan. 20, 2016  Synaptics Incorporated ... human interface solutions, today announced sampling of S1423, ... for wearables and small screen applications including smartwatches, ... printers. Supporting round and rectangular shapes, as well ... excellent performance with moisture on screen, while wearing ...
Breaking Biology News(10 mins):